Press Releases from DelveInsight Business Research (5349 total)
Colorectal Cancer Treatment Drugs, Clinical Trials, and Companies 2024
DelveInsight's, "Colorectal Cancer Pipeline Insight 2024" report provides comprehensive insights about 195+ companies and 200+ pipeline drugs in Colorectal Cancer pipeline landscape. It covers the…
Non-Small Cell Lung Cancer Clinical Trials 2024: FDA Approvals, Pipeline, Therap …
DelveInsight's, "Non-Small-Cell Lung Cancer Pipeline Insight 2024" report provides comprehensive insights about 135+ Non-Small Cell Lung Cancer Companies and 150+ pipeline drugs in the Non-Small-Cell…
Sphingosine 1 Phosphate Receptor (S1PR) Modulators Market Projected for Strong G …
(Albany, USA) DelveInsight's Sphingosine 1 Phosphate Receptor (S1PR) Modulators Market Insights report offers a thorough understanding of prevailing treatment protocols, emerging therapies, individual therapy market…
Opioid Kappa Receptor Agonists Market Poised for Remarkable Growth by 2034, Repo …
(Albany, USA) DelveInsight's Opioid Kappa Receptor Agonists Market Insights report offers a thorough understanding of prevailing treatment protocols, emerging therapies, individual therapy market shares, and…
Tinnitus Clinical Trials 2024: FDA Approvals, Pipeline, Therapies, Treatment Mar …
(Albany, USA) Tinnitus pipeline constitutes 7+ key companies continuously working towards developing 8+ Tinnitus treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route…
Cervical Cancer Clinical Trials 2024: FDA Approvals, Pipeline, Therapeutic Advan …
(Albany, United States) As per DelveInsight's assessment, globally, Cervical Cancer pipeline constitutes 70+ key companies continuously working towards developing 70+ Cervical Cancer treatment therapies, analysis…
Cervical Cancer Clinical Trials 2024: FDA Approvals, Pipeline, Therapeutic Advan …
(Albany, United States) As per DelveInsight's assessment, globally, Cervical Cancer pipeline constitutes 70+ key companies continuously working towards developing 70+ Cervical Cancer treatment therapies, analysis…
Atopic Dermatitis Clinical Trials 2024: FDA Approvals, Pipeline, Therapeutic Inn …
(Albany, United States) As per DelveInsight's assessment, globally, Atopic Dermatitis pipeline constitutes 100+ key companies continuously working towards developing 110+ Atopic Dermatitis treatment therapies, analysis…
Ewing Sarcoma Clinical Trials 2024: FDA Approvals, Pipeline, Therapies, ROA, MOA …
Ewing Sarcoma pipeline constitutes 25+ key companies continuously working towards developing 25+ Ewing Sarcoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route…
Pancreatic Ductal Adenocarcinoma Clinical Trials Analysis 2024: FDA Approvals, P …
(Albany, United States) As per DelveInsight's assessment, globally, Pancreatic Ductal Adenocarcinoma pipeline constitutes 80+ key companies continuously working towards developing 80+ Pancreatic Ductal Adenocarcinoma treatment…
OX40 Ligand Inhibitors Market is expected to Sour at a decent CAGR by 2034, Feat …
(Albany, USA) DelveInsight's OX40 Ligand Inhibitors Market Insights report offers a thorough understanding of prevailing treatment protocols, emerging therapies, individual therapy market shares, and the…
Glucagon-Like Peptide-1 (GLP-1) Agonists Market is projected to Grow during the …
(Albany, USA) DelveInsight's Glucagon-like Peptide-1 (GLP-1) Agonists Market Insights report offers a thorough understanding of prevailing treatment protocols, emerging therapies, individual therapy market shares, and…
Phosphodiesterase-4 (PDE4) Inhibitor Market: Projected Significant Growth During …
(Albany, USA) The Phosphodiesterase-4 (PDE4) Inhibitor market size is anticipated to increase in the study period due to a direct consequence of an increase in…
Janus kinase (JAK) Inhibitor Market is expected to Grow by 2034, estimates Delve …
(Albany, USA) DelveInsight's Janus kinase (JAK) Inhibitor Market Insights report includes a comprehensive understanding of current treatment practices, emerging Janus kinase (JAK) Inhibitor, market share…
Diabetic Foot Ulcer Treatment Market 2034: Epidemiology, FDA Approvals, Clinical …
(Albany, USA) DelveInsight's "Diabetic Foot Ulcer Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of Diabetic Foot Ulcer (DFU) ,…
Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) Clinical Trial …
(Albany, United States) "Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and…
HDAC Inhibitor Clinical Trials Analysis 2024 (Updated): FDA Approvals, Pipeline, …
(Albany, United States) As per DelveInsight's assessment, globally, HDAC Inhibitor pipeline constitutes 50+ key companies continuously working towards developing 50+ HDAC Inhibitor treatment therapies, analysis…
Fabry Disease Market to Sour at a CAGR of ~6% by 2032, estimates DelveInsight | …
(Albany, USA) DelveInsight's "Fabry Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Fabry Disease, historical and forecasted epidemiology as well…
Secondary Hyperparathyroidism Treatment Market 2032: Clinical Trials, FDA Approv …
(Albany, USA) DelveInsight's "Secondary Hyperparathyroidism Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Secondary Hyperparathyroidism, historical and forecasted epidemiology as well…
Atypical Hemolytic Uremic Syndrome Treatment Market 2034: Epidemiology, FDA Appr …
(Albany, USA) DelveInsight's "Atypical Hemolytic Uremic Syndrome Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Atypical Hemolytic Uremic Syndrome, historical and…
Epilepsy Clinical Trials Analysis 2024 (Updates): FDA Approvals, Therapies, Pipe …
(Albany, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical…
Anti-CD19 Antibody Clinical Trials Analysis 2024 (Updates): FDA Approvals, Thera …
(Albany, United States) As per DelveInsight's assessment, globally, Anti-CD19 Antibody pipeline constitutes key companies continuously working towards developing Anti-CD19 Antibody treatment therapies, analysis of Clinical…
Yellow Fever Clinical Trials Analysis 2024 (Updates): FDA Approvals, Pipeline, T …
(Albany, United States) As per DelveInsight's assessment, globally, Yellow Fever pipeline constitutes 3+ key companies continuously working towards developing 3+ Yellow Fever treatment therapies, analysis…
Acute Ischemic Stroke Clinical Trials Analysis 2024 (Updates): FDA Approvals, Pi …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Acute Ischemic Stroke pipeline constitutes 30+ key companies continuously working towards developing 30+ Acute Ischemic…
Duchenne Muscular Dystrophy Clinical Trials Analysis 2024: FDA Approval, Pipelin …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Duchenne Muscular Dystrophy pipeline constitutes 75+ key companies continuously working towards developing 75+ Duchenne Muscular…
PD-1 NSCLC Clinical Trials Analysis 2024: FDA Approvals, Pipeline, Therapeutic A …
(Albany, United States) As per DelveInsight's assessment, globally, PD-1 Non-Small Cell Lung Cancer pipeline constitutes 30+ key companies continuously working towards developing 30+ PD-1 Non-Small…
Alopecia Areata Clinical Trials 2024: FDA Approvals, Pipeline, Therapies, Compan …
(Albany, United States) As per DelveInsight's assessment, globally, Alopecia Areata pipeline constitutes 18+ key companies continuously working towards developing 20+ Alopecia Areata treatment therapies, analysis…
Anemia In Chronic Kidney Disease Clinical Trials 2024: Pipeline Assessment, FDA …
(Albany, United States) As per DelveInsight's assessment, globally, Anemia In Chronic Kidney Disease pipeline constitutes 10+ key companies continuously working towards developing 10+ Anemia In…
Bipolar Disorder Clinical Trials 2024: FDA Approvals, Pipeline, Therapies, Compa …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Bipolar Disorder pipeline constitutes 22+ key companies continuously working towards developing 22+ Bipolar Disorder treatment…
Cold Agglutinin Disease Treatment Market 2034: FDA Approvals, Clinical Trials, D …
DelveInsight's "Cold Agglutinin Disease Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Cold Agglutinin Disease, historical and forecasted epidemiology as…
Hereditary Angioedema Treatment Market 2032: FDA Approvals, Clinical Trials, Dru …
DelveInsight's "Hereditary Angioedema Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Hereditary Angioedema, historical and forecasted epidemiology as well as…
Benign Breast Disease and Early Breast Cancer Market Forecast 2034: Clinical Tri …
(Albany, USA) DelveInsight's "Benign Breast Disease and Early Breast Cancer Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Benign Breast…
Respiratory Disease Testing Market to Sour at a CAGR of 5.14% by 2030, Evaluates …
As per DelveInsight's assessment, the Respiratory Disease Testing Market is expected to grow at an immense pace in the coming years owing to the The…
Chemotherapy-induced Thrombocytopenia Treatment Market 2032: FDA Approvals, Clin …
(Albany, USA) DelveInsight's "Chemotherapy-induced Thrombocytopenia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Chemotherapy-induced Thrombocytopenia, historical and forecasted epidemiology as…
Influenza Virus B Infections Clinical Trials Analysis 2024: EMA, PDMA, FDA Appro …
(Albany, USA) As per DelveInsight's assessment, globally, about 10+ key pharma and biotech companies are working on 10+ pipeline drugs in the Influenza Virus B…
Lung Adenocarcinoma Clinical Trials Analysis 2024: EMA, PDMA, FDA Approvals, Pip …
(Albany, USA) As per DelveInsight's assessment, globally, about 25+ key pharma and biotech companies are working on 25+ pipeline drugs in the Lung Adenocarcinoma therapeutics…
Rheumatoid Arthritis Clinical Trials 2024: FDA, EMA, PMDA Approvals, Pipeline, T …
(Albany, USA) Rheumatoid Arthritis pipeline report including 120+ key companies and 120+ Rheumatoid Arthritis treatment therapies, analyses DelveInsight
"Rheumatoid Arthritis Pipeline Insight, 2024" report by DelveInsight…
Glioblastoma Clinical Trials Analysis 2024: FDA Approvals, Pipeline, Therapies, …
(Albany, USA) As per DelveInsight's assessment, globally, Glioblastoma pipeline constitutes 190+ key companies continuously working towards developing 200+ Glioblastoma treatment therapies, analysis of Clinical Trials,…
Janus Kinase (JAK) Inhibitors Clinical Trials 2024: Recent Breakthroughs, FDA Ap …
(Albany, United States) As per DelveInsight's assessment, globally, Janus Kinase (JAK) Inhibitors pipeline constitutes key companies continuously working towards developing Janus Kinase (JAK) Inhibitors treatment…
Atypical Teratoid Rhabdoid Tumors (ATRT) Clinical Trials Updates 2024: Recent Br …
(Albany, USA) Atypical Teratoid Rhabdoid Tumors pipeline constitutes 5+ key companies continuously working towards developing 5+ Atypical Teratoid Rhabdoid Tumors treatment therapies, analysis of Clinical…
Ewing Sarcoma Clinical Trials Updates 2024: Recent Breakthroughs, Pipeline, FDA …
(Albany, USA) Ewing Sarcoma pipeline constitutes 25+ key companies continuously working towards developing 25+ Ewing Sarcoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of…
Bladder Pain Syndrome Treatment Market 2032: Clinical Trials, Prevalence, FDA Ap …
(Albany, USA) DelveInsight's "Bladder Pain Syndrome Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Bladder Pain Syndrome, historical and forecasted…
CAR-T Cell Therapy Clinical Trials Analysis 2024: FDA Approvals, Pipeline, Thera …
(Albany, USA) DelveInsight's, "CAR T Cell Therapy Competitive Landscape 2024" report provides comprehensive insights about 250+ CAR-T Cell Therapy companies and 500+ drugs in CAR…
Gene therapy Treatment Pipeline Analysis 2024: FDA Approvals, Clinical Trials, T …
(Albany, USA) DelveInsight's, "Gene Therapy Competitive Landscape 2024" report provides comprehensive insights about 250+ Gene Therapy companies and 300+ Gene Therapy drugs in the Gene…
Bispecific Antibody Clinical Trials Analysis 2024: FDA Approvals, Pipeline, Ther …
(Albany, USA) DelveInsight's, "Bispecific antibody Competitive landscape" report provides comprehensive insights about 250+ Bispecific Antibody companies and 300+ Bispecific Antibody drugs in Bispecific antibody Competitive…
Antibody Drug Conjugate Clinical Trials Analysis 2024: FDA Approvals, Pipeline, …
(Albany, USA) DelveInsight's, "Antibody Drug Conjugate Competitive Landscape" report provides comprehensive insights about 180+ Antibody Drug Conjugate companies and 290+ Antibody Drug Conjugate drugs in…
Hidradenitis Suppurativa Treatment Market 2034: FDA Approvals, Clinical Trials, …
DelveInsight's "Hidradenitis Suppurativa Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of Hidradenitis Suppurativa, historical and forecasted epidemiology as well…
EGFR-Positive Non-Small Cell Lung Cancer (EGFR+ NSCLC) Clinical Trials Assessmen …
(Albany, USA) As per DelveInsight's assessment, globally, about 40+ key pharma and biotech companies are working on 42+ pipeline drugs in the EGFR-Positive Non-Small Cell…
Retinitis Pigmentosa Clinical Trials Assessment 2024: FDA Approvals, Pipeline, T …
(Albany, USA) As per DelveInsight's assessment, globally, about 25+ key pharma and biotech companies are working on 30+ Retinitis Pigmentosa pipeline drugs in the therapeutics…
Asthma Clinical Trials Assessment 2024: FDA Approvals, Pipeline, Therapies, MOA, …
(Albany, USA) DelveInsight's 'Asthma Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline asthma therapies in various stages of clinical development,…
